1. The Presence of an Aberrant Right Hepatic Artery Did Not Influence Surgical and Oncological Outcomes After Pancreaticoduodenectomy: A Comprehensive Systematic Review and Meta-Analysis.
- Author
-
Ricci, Claudio, Alberici, Laura, Minghetti, Margherita, Ingaldi, Carlo, Grego, Davide Giovanni, D'Ambra, Vincenzo, De Dona, Ermenegilda, and Casadei, Riccardo
- Subjects
- *
PANCREATICODUODENECTOMY , *HEPATIC artery , *RANDOM effects model , *PANCREATIC fistula , *GASTRIC emptying , *OVERALL survival - Abstract
Background: The presence of an aberrant right hepatic artery (a-RHA) could influence the oncological and postoperative results after pancreaticoduodenectomy (PD). Methods: A systematic review and metanalysis were conducted, including all comparative studies having patients who underwent PD without (na-RHA) or with a-RHA. The results were reported as risk ratios (RRs), mean differences (MDs), or hazard ratios (HRs) with 95% confidence intervals (95 CI). The random effects model was used to calculate the effect sizes. The endpoints were distinguished as critical and important. Critical endpoints were: R1 resection, overall survival (OS), morbidity, mortality, and biliary fistula (BL). Important endpoints were: postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE), post pancreatectomy hemorrhage (PPH), length of stay (LOS), and operative time (OT). Results: Considering the R1 rate no significant differences were observed between the two groups (RR 1.06; 0.89 to 1.27). The two groups have a similar OS (HR 0.95; 0.85 to 1.06). Postoperative morbidity and mortality were similar between the two groups, with a RR of 0.97 (0.88 to 1.06) and 0.81 (0.54 to 1.20), respectively. The biliary fistula rate was similar between the two groups (RR of 1.09; 0.72 to 1.66). No differences were observed for non-critical endpoints. Conclusion: The presence of a-RHA does not affect negatively the short-term and long-term clinical outcomes of PD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF